Skip to main content
. 2020 Jan;26(1):138–142. doi: 10.3201/eid2601.191110

Table 2. Projected effect of pediatric LAIV on adverse health outcomes associated with antibiotic resistance, England and Wales*.

Outcome Estimate for 2015,
England and Wales Projected reduction in outcome resulting from LAIV, mean (95% HDI)
DALYs 46,039 642 (450–842)
Cases 47,080 432 (303–566)
Deaths 1,930 22 (16–29)

*DALYs, disability-adjusted life years; HDI, highest density interval; LAIV, live attenuated influenza vaccine.